A citation-based method for searching scientific literature

Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
Times Cited: 80



Andrew Mancini, Ana Xavier-Magalhães, Wendy S Woods, Kien-Thiet Nguyen, Alexandra M Amen, Josie L Hayes, Christof Fellmann, Michael Gapinske, Andrew M McKinney, Chibo Hong, Lindsey E Jones, Kyle M Walsh, Robert J A Bell, Jennifer A Doudna, Bruno M Costa, Jun S Song, Pablo Perez-Pinera, Joseph F Costello. Cancer Cell 2018
Times Cited: 46




List of shared articles



Times cited

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou. NPJ Precis Oncol 2021
2

Occurrence, functionality and abundance of the TERT promoter mutations.
Sivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar. Int J Cancer 2021
1

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
1

Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Josh Lewis Stern, Grace Hibshman, Kevin Hu, Sarah E Ferrara, James C Costello, William Kim, Pablo Tamayo, Thomas R Cech, Franklin W Huang. Mol Cancer Res 2020
8

Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2020
2


TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
16


TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma.
Lisa Gabler, Daniela Lötsch, Dominik Kirchhofer, Sushilla van Schoonhoven, Hannah M Schmidt, Lisa Mayr, Christine Pirker, Katharina Neumayer, Carina Dinhof, Lucia Kastler,[...]. Acta Neuropathol Commun 2019
13

Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
15

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Neeraj Agarwal, Sebastien Rinaldetti, Bassem B Cheikh, Qiong Zhou, Evan P Hass, Robert T Jones, Molishree Joshi, Daniel V LaBarbera, Simon R V Knott, Thomas R Cech,[...]. Proc Natl Acad Sci U S A 2021
0